About Ori Biotech
Ori Biotech is a Healthcare company based in London (United Kingdom) founded in 2015 by Chris Mason and Farlan Veraitch. Software development services are provided for the biopharma sector. Ori Biotech has raised $281.12 million across 6 funding rounds from investors including Novalis LifeSciences, Puhua Capital and Chimera Investment. Ori Biotech was last valued at $62.6 million in September 2020. Its chief executive, as recorded, is Jason C Foster. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Lab Automation. Its legal entity is ORIBIOTECH LTD.
Company details
Ori Biotech was founded in 2015 and is based in London, United Kingdom. Software development services tailored to the biopharma sector are delivered by the company. Operations center on creating tools and solutions for biopharmaceutical processes. Leadership includes Co-Founders Chris Mason and Farlan Veraitch, alongside CEO Jason C Foster. Focus remains on supporting sector-specific needs through technical expertise.
- Headquarters London, United Kingdom
- Founders Chris Mason, Farlan Veraitch
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website oribiotech.com
- Social LinkedIn X YouTube
- Legal Name Oribiotech Ltd
- Date of Incorporation 02 Sep, 2015
- Jurisdiction LONDON, UNITED KINGDOM
- Total Equity Funding$281.12M (USD)
in 6 rounds
- Latest Funding Round$138.7M (USD), Series B
Jun 2022
- InvestorsNovalis LifeSciences
& 7 more
Apps and channels of Ori Biotech
its YouTube channel Ori Biotech has 92 subscribers and 30 videos.
Videos from Ori Biotech
The most watched videos on Ori Biotech's YouTube channel, Ori Biotech (92 subscribers). Click a video to play it here.
More on Ori Biotech.
Funding Insights of Ori Biotech
Ori Biotech has successfully raised a total of $281.12M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $138.7 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $281.12M
- Total Rounds 6
- Last Round Series B — $138.7M
- Investors Count 8
All 6 funding rounds of Ori Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $138.7M | Series B | – | – | – |
| Jan 2022 | $102.48M | Series B | – | Novalis LifeSciences | |
| Sep 2020 | $30.3M | Series A | $62.6M | Northpond Ventures, Octopus Ventures | |
| Aug 2019 | $9.4M | Seed | $13.43M | Amadeus Capital, Delin Ventures | – |
| Nov 2017 | $230,616 | Seed | – | – | – |
| Nov 2016 | Seed | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2020 | $62.6M | •••••••• |
| Aug 2019 | $13.43M | •••••••• |
Last known valuation $62.6M (Sep 2020). 8 investors in total: 8 institutional.
Investors in Ori Biotech
Ori Biotech has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Novalis LifeSciences, Puhua Capital and Chimera Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment and advisory services are provided for life sciences. | 2017 | novalislifesciences.com | Portsmouth, USA | |
Health and technology startups are invested in by Puhua Capital. | puhuacapital.com | Hangzhou, China | ||
A private investment firm focused on regional opportunities. | chimerainvestment.com | Abu Dhabi, United Arab Emirates | ||
Early-stage deep technology investments are made by Amadeus Capital. | amadeuscapital.com | London, United Kingdom | ||
Delin Ventures is engaged in investing and building companies in life sciences and technology sectors. | delinventures.com | |||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Venture capital investment and support for founders in technology and health sectors. | octopusventures.com | |||
Venture capital funding is offered to pre-seed and seed startups. | 2015 | kindredcapital.vc |
Investor details for Ori Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ori Biotech
42 people are tracked at Ori Biotech (11 in leadership, 14 in board & advisors, 17 in team).
| Name | Role | Group |
|---|---|---|
Chris Mason | Co-Founder | Leadership |
Farlan Veraitch | Co-Founder & Chief Scientific Officer | Leadership |
Jason C Foster | CEO | Leadership |
Derek Bean | Associate Director, Consumables | Leadership |
Lee Unroe | VP, Marketing | Leadership |
Arman Amini | Director Of Bioprocessing | Leadership |
Stuart Milne | Chief Technology Officer | Leadership |
Thomas Heathman | VP, Commercial Operations | Leadership |
Richard Meechan | Director of Manufacturing & Supply | Leadership |
Keara Traylor | Senior Director, Technical Solutions | Leadership |
Kale Feeter | Vice President, Business Development | Leadership |
Will Tracey | Director | Board & advisors |
Jian Irish | Advisor | Board & advisors |
Bruce Levine | Advisor | Board & advisors |
Adam Wieschhaus | Director | Board & advisors |
Pierre Socha | Director | Board & advisors |
Barry Clare | Chairman | Board & advisors |
Alvin Nienow | Advisor | Board & advisors |
Deanna Petersen | Advisor | Board & advisors |
Jonathan Hay | Director | Board & advisors |
22 more people are available in the full profile.
Complete people profiles for Ori Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ori Biotech
4 dated milestones of Ori Biotech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Ori Biotech is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $138.7M.
Web traffic of Ori Biotech
The website of Ori Biotech (oribiotech.com) receives about 9.1K visits a month and ranks #1,722,992 among all websites worldwide, #2,334 in Biotechnology and Pharmaceuticals.
- Monthly visits9.1K
- Unique visitors3.5K
per month
- Global rank#1,722,992
among all websites
- Category rank#2,334
Health · Biotechnology and Pharmaceuticals
- Bounce rate25%
- Pages per visit4.9
- Average visit2 min 46 sec
- DevicesDesktop 67% · Mobile 33%
Websites whose visitors overlap most with Ori Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| trinitybiotech.com | 100% | 9.3K | #2,475,266 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Ori Biotech (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ori Biotech
Complete news archive for Ori Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ori Biotech
Ori Biotech was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Ori Biotech is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jason C Foster is the CEO of Ori Biotech, as recorded in our data.
Ori Biotech is a funded company, having raised a total of $281.12M across 6 funding rounds to date.
Ori Biotech was founded in 2015 and is based in London, United Kingdom. Software development services tailored to the biopharma sector are delivered by the company. Operations center on creating tools and solutions for biopharmaceutical processes. Leadership includes Co-Founders Chris Mason and Farlan Veraitch, alongside CEO Jason C Foster. Focus remains on supporting sector-specific needs through technical expertise.
Ori Biotech has 8 investors. Key investors include Novalis LifeSciences, Puhua Capital, Chimera Investment, Amadeus Capital Partners, and Delin Ventures.
The valuation of Ori Biotech is $62.6M as of Sep 2020.
Ori Biotech operates through Oribiotech Ltd.